Neuro Endocrine (Carcinoid) Carcinoma Global Clinical Trials Review, H1, 2012

GlobalData, February 2012, Pages: 95

Neuro Endocrine (Carcinoid) Carcinoma Global Clinical Trials Review, H1, 2012

Summary

GlobalData's clinical trial report, “Neuro Endocrine (Carcinoid) Carcinoma Global Clinical Trials Review, H1, 2012" provides data on the Neuro Endocrine (Carcinoid) Carcinoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Neuro Endocrine (Carcinoid) Carcinoma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Neuro Endocrine (Carcinoid) Carcinoma. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Keywords

Neuro Endocrine (Carcinoid) Carcinoma Clinical Trials, Trial Designs, Subjects Recruited, Unaccomplished Trials of Neuro Endocrine (Carcinoid) Carcinoma , Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas, M.D. Andersons, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, National Cancer Center, University of Pennsylvania.

List of Tables
List of Figures
Introduction
Neuro Endocrine (Carcinoid) Carcinoma
Report Guidance
Clinical Trials by Region
Clinical Trials by Country
Top Countries Contributing to Clinical Trials in Asia-Pacific
Top Five Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Top Countries Contributing to Clinical Trials in Middle East and Africa
Top Countries Contributing to Clinical Trials in Central and South America
Clinical Trials by BRIC Nations
Clinical Trials by G7 Nations
Clinical Trials in G7 Nations by Trial Status
Clinical Trials by E7 Nations
Clinical Trials in E7 Nations by Trial Status
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Unaccomplished Trials of Neuro Endocrine (Carcinoid) Carcinoma
Subjects Recruited Over a Period of Time
Prominent Sponsors
Top Companies Participating in Neuro Endocrine (Carcinoid) Carcinoma Therapeutics Clinical Trials
Prominent Drug Comparison
Clinical Trial Profiles
Clinical Trial Overview of Top Companies
Ipsen Limited
Clinical Trial Overview of Ipsen Limited
Molecular Insight Pharmaceuticals, Inc.
Clinical Trial Overview of Molecular Insight Pharmaceuticals, Inc.
Cylene Pharmaceuticals, Inc.
Clinical Trial Overview of Cylene Pharmaceuticals, Inc.
Burzynski Research Institute, Inc.
Clinical Trial Overview of Burzynski Research Institute, Inc.
Neotropix, Inc.
Clinical Trial Overview of Neotropix, Inc.
Callisto Pharmaceuticals, Inc.
Clinical Trial Overview of Callisto Pharmaceuticals, Inc.
EntreMed, Inc.
Clinical Trial Overview of EntreMed, Inc.
MannKind Corporation
Clinical Trial Overview of MannKind Corporation
Pfizer Inc.
Clinical Trial Overview of Pfizer Inc.
ImmunoGen, Inc.
Clinical Trial Overview of ImmunoGen, Inc.
ImClone LLC
Clinical Trial Overview of ImClone LLC
Ipsen S.A.
Clinical Trial Overview of Ipsen S.A.
Precision Therapeutics, Inc.
Clinical Trial Overview of Precision Therapeutics, Inc.
Amgen Inc.
Clinical Trial Overview of Amgen Inc.
Clinical Trial Overview of Top Universities / Institutes / Hospitals
The University of Texas M. D. Anderson Cancer Center
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center
Dana-Farber Cancer Institute
Clinical Trial Overview of Dana-Farber Cancer Institute
Stanford University
Clinical Trial Overview of Stanford University
Mayo Clinic
Clinical Trial Overview of Mayo Clinic
The University of Western Ontario
Clinical Trial Overview of The University of Western Ontario
University of California, San Francisco
Clinical Trial Overview of University of California, San Francisco
Hadassah Medical Organization
Clinical Trial Overview of Hadassah Medical Organization
University of Turin
Clinical Trial Overview of University of Turin
University Medical Center Groningen
Clinical Trial Overview of University Medical Center Groningen
Fred Hutchinson Cancer Research Center
Clinical Trial Overview of Fred Hutchinson Cancer Research Center
Rutgers, The State University of New Jersey
Clinical Trial Overview of Rutgers, The State University of New Jersey
Assistance Publique Hopitaux De Marseille
Clinical Trial Overview of Assistance Publique Hopitaux De Marseille
Columbia University
Clinical Trial Overview of Columbia University
Sidney Kimmel Comprehensive Cancer Center
Clinical Trial Overview of Sidney Kimmel Comprehensive Cancer Center
Tel-Aviv Sourasky Medical Center
Clinical Trial Overview of Tel-Aviv Sourasky Medical Center
H. Lee Moffitt Cancer Center & Research Institute
Clinical Trial Overview of H. Lee Moffitt Cancer Center & Research Institute
University Health Network
Clinical Trial Overview of University Health Network
Boston Medical Center
Clinical Trial Overview of Boston Medical Center
University of New Mexico
Clinical Trial Overview of University of New Mexico
Five Key Clinical Profiles
Appendix
Abbreviations
Definitions
Research Methodology
Secondary Research
About GlobalData
Contact Us
Disclaimer
Source

List of Tables
Neuro Endocrine (Carcinoid) Carcinoma Therapeutics Market, Global, Clinical Trials by Zone, 2012-
Neuro Endocrine (Carcinoid) Carcinoma Therapeutics Market, Global, Clinical Trials by Top Countries, 2012-
Neuro Endocrine (Carcinoid) Carcinoma Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012-
Neuro Endocrine (Carcinoid) Carcinoma Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2012-
Neuro Endocrine (Carcinoid) Carcinoma Therapeutics Clinical Trials, Europe, Top Five Countries, 2012-
Neuro Endocrine (Carcinoid) Carcinoma Therapeutics Clinical Trials, North America, Top Countries, 2012-
Neuro Endocrine (Carcinoid) Carcinoma Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2012-
Neuro Endocrine (Carcinoid) Carcinoma Therapeutics Clinical Trials, Central and South America, Top Countries, 2012-
Neuro Endocrine (Carcinoid) Carcinoma Therapeutics Clinical Trials, BRIC Countries, 2012-
Neuro Endocrine (Carcinoid) Carcinoma Therapeutics Clinical Trials, G7 Countries, 2012-
Neuro Endocrine (Carcinoid) Carcinoma Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012-
Neuro Endocrine (Carcinoid) Carcinoma Therapeutics Clinical Trials, E7 Countries, 2012-
Neuro Endocrine (Carcinoid) Carcinoma Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012-
Neuro Endocrine (Carcinoid) Carcinoma Therapeutics Market, Global, Clinical Trials by Phase, 2012-
Neuro Endocrine (Carcinoid) Carcinoma Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012-
Neuro Endocrine (Carcinoid) Carcinoma Therapeutics Market, Global, Clinical Trials by Trial Status, 2012-
Neuro Endocrine (Carcinoid) Carcinoma Therapeutics Market, Global, Withdrawn Clinical Trials, 2012-
Neuro Endocrine (Carcinoid) Carcinoma Therapeutics Market, Global, Terminated Clinical Trials, 2012-
Neuro Endocrine (Carcinoid) Carcinoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010
Neuro Endocrine (Carcinoid) Carcinoma Therapeutics Clinical Trials, Global, Key Sponsors, 2012-
Neuro Endocrine (Carcinoid) Carcinoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012-
Neuro Endocrine (Carcinoid) Carcinoma Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012-
Neuro Endocrine (Carcinoid) Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Ipsen Limited, 2012-
Neuro Endocrine (Carcinoid) Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Molecular Insight Pharmaceuticals, Inc., 2012-
Neuro Endocrine (Carcinoid) Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Cylene Pharmaceuticals, Inc., 2012-
Neuro Endocrine (Carcinoid) Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Burzynski Research Institute, Inc., 2012-
Neuro Endocrine (Carcinoid) Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Neotropix, Inc., 2012-
Neuro Endocrine (Carcinoid) Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Callisto Pharmaceuticals, Inc., 2012-
Neuro Endocrine (Carcinoid) Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by EntreMed, Inc., 2012-
Neuro Endocrine (Carcinoid) Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by MannKind Corporation, 2012-
Neuro Endocrine (Carcinoid) Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2012-
Neuro Endocrine (Carcinoid) Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by ImmunoGen, Inc., 2012-
Neuro Endocrine (Carcinoid) Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by ImClone LLC, 2012-
Neuro Endocrine (Carcinoid) Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Ipsen S.A., 2012-
Neuro Endocrine (Carcinoid) Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Precision Therapeutics, Inc., 2012-
Neuro Endocrine (Carcinoid) Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2012-
Neuro Endocrine (Carcinoid) Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2012-
Neuro Endocrine (Carcinoid) Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2012-
Neuro Endocrine (Carcinoid) Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Dana-Farber Cancer Institute, 2012-
Neuro Endocrine (Carcinoid) Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Stanford University, 2012-
Neuro Endocrine (Carcinoid) Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2012-
Neuro Endocrine (Carcinoid) Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Western Ontario, 2012-
Neuro Endocrine (Carcinoid) Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Francisco, 2012-
Neuro Endocrine (Carcinoid) Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Hadassah Medical Organization, 2012-
Neuro Endocrine (Carcinoid) Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Turin, 2012-
Neuro Endocrine (Carcinoid) Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by University Medical Center Groningen, 2012-
Neuro Endocrine (Carcinoid) Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Fred Hutchinson Cancer Research Center, 2012-
Neuro Endocrine (Carcinoid) Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Rutgers, The State University of New Jersey, 2012-
Neuro Endocrine (Carcinoid) Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique Hopitaux De Marseille, 2012-
Neuro Endocrine (Carcinoid) Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Columbia University, 2012-
Neuro Endocrine (Carcinoid) Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Sidney Kimmel Comprehensive Cancer Center, 2012-
Neuro Endocrine (Carcinoid) Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Tel-Aviv Sourasky Medical Center, 2012-
Neuro Endocrine (Carcinoid) Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by H. Lee Moffitt Cancer Center & Research Institute, 2012-
Neuro Endocrine (Carcinoid) Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by University Health Network, 2012-
Neuro Endocrine (Carcinoid) Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Boston Medical Center, 2012-
Neuro Endocrine (Carcinoid) Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by University of New Mexico, 2012-

List of Figures
Neuro Endocrine (Carcinoid) Carcinoma Therapeutics Market, Global, Clinical Trials by Zone (%), 2012-
Neuro Endocrine (Carcinoid) Carcinoma Therapeutics Market, Global, Clinical Trials by Top Countries, 2012-
Neuro Endocrine (Carcinoid) Carcinoma Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012-
Neuro Endocrine (Carcinoid) Carcinoma Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2012-
Neuro Endocrine (Carcinoid) Carcinoma Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012-
Neuro Endocrine (Carcinoid) Carcinoma Therapeutics Clinical Trials, North America, Top Countries (%), 2012-
Neuro Endocrine (Carcinoid) Carcinoma Therapeutics Clinical Trials, G7 Countries (%), 2012-
Neuro Endocrine (Carcinoid) Carcinoma Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012-
Neuro Endocrine (Carcinoid) Carcinoma Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012-
Neuro Endocrine (Carcinoid) Carcinoma Therapeutics Market, Global, Clinical Trials by Phase (%), 2012-
Neuro Endocrine (Carcinoid) Carcinoma Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012-
Neuro Endocrine (Carcinoid) Carcinoma Therapeutics Market, Global, Clinical Trials by Trial Status, 2012-
Neuro Endocrine (Carcinoid) Carcinoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010
Neuro Endocrine (Carcinoid) Carcinoma Therapeutics Clinical Trials, Global, Key Sponsors, 2012-
Neuro Endocrine (Carcinoid) Carcinoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012-
Neuro Endocrine (Carcinoid) Carcinoma Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012-
GlobalData Methodology

Customers who bought this item also bought

• Bronchitis Global Clinical Trials Review, H2, 2012
• Cachexia Global Clinical Trials Review, H1, 2013
• Osteoporosis Global Clinical Trials Review, H2, 2012
• Shock Global Clinical Trials Review, H2, 2012
• Other Metabolic Disorders Global Clinical Trials Review, H1, 2012
• Atopic Dermatitis (Eczema) Global Clinical Trials Review, H1, 2012
• Asthma Global Clinical Trials Review, H1, 2012
• Alopecia Global Clinical Trials Review, H1, 2013
• Sleep Apnea Global Clinical Trials Review, H1, 2012
• Sickle Cell Disease Global Clinical Trials Review, H2, 2012